SC-VC-PAB-MMAE

SC-VC-PAB-MMAE (NHS-VC-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB[1].

Product Specifications

CAS Number

[2259318-46-0]

Product Name Alternative

NHS-VC-PAB-MMAE

UNSPSC

12352203

Hazard Statement

H300+H330, H340, H360, H370, H372, H412

Target

Drug-Linker Conjugates for ADC

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/sc-vc-pab-mmae.html

Purity

99.29

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCC(ON1C(CCC1=O)=O)=O)=O)=O)NC(C=C2)=CC=C2COC(N(C)[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(N3[C@H]([C@H](OC)[C@@H](C)C(N[C@@H]([C@@H](O)C4=CC=CC=C4)C)=O)CCC3)=O)=O)=O)=O